SCHEMBL19509239

SCHEMBL19509239

CC(=O)[C@H](C)CCC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 3/20 0.42
ALDH1A1 P00352 4/20 0.42
GRIN2D O15399 3/20 0.41
GRIN3B O60391 3/20 0.41
GRIN1 Q05586 3/20 0.41
GRIN2A Q12879 3/20 0.41
GRIN2B Q13224 3/20 0.41
GRIN2C Q14957 3/20 0.41
GRIN3A Q8TCU5 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TSHR P16473 2/20 0.39
EPHX1 P07099 1/20 0.38
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16147061 0.85 SMN1; SMN2 (0.50) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL15648853 0.85 SMN1; SMN2 (0.50) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL27437026 0.83 MEN1 (0.45) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL19500377 0.81 KMT2A (0.41) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL22131563 0.77 EPHX2 (0.42) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL27437149 0.76 MEN1 (0.41) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL10759080 0.75 SMN1; SMN2 (0.47) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL1524675 0.72 GRIN2D (0.46) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1
SCHEMBL13780945 0.72 MEN1 (0.49) KMT2AMEN1EPHX2ALDH1A1GRIN2D
SCHEMBL25836653 0.72 GRIN2D (0.46) KMT2AMEN1SMN1; SMN2EPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170307614-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same UNIV YALE (US) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170307614-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same HSP90B1, LAMP2, PSMG3 KMT2A 3767/4885MEN1 2899/4885SMN1; SMN2 3540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.